Show simple item record

Eribulin in metastatic breast cancer the UK experience: a multi-centre retrospective 577 patient study

dc.contributor.authorJafri, M
dc.contributor.authorKristeleit, H
dc.contributor.authorMisra, Vivek
dc.contributor.authorBaxter, M
dc.contributor.authorAhmed, S
dc.contributor.authorJegnnathen, A
dc.contributor.authorJain, A
dc.contributor.authorMaskell, D
dc.contributor.authorBarthakur, U
dc.contributor.authorEdwards, G
dc.contributor.authorWalter, H
dc.contributor.authorWalter, R
dc.contributor.authorKhan, M
dc.contributor.authorBorley, A
dc.contributor.authorNightingale, P
dc.contributor.authorRea, D
dc.date.accessioned2019-04-29T09:49:01Z
dc.date.available2019-04-29T09:49:01Z
dc.date.issued2018en
dc.identifier.citationJafri M, Kristeleit H, Misra V, Baxter MA, Ahmed S, Jegnnathen A, et al. 313P Eribulin in metastatic breast cancer the UK experience: a multi-centre retrospective 577 patient study. Ann Oncol. 2018;29(suppl_8):100.en
dc.identifier.doi10.1093/annonc/mdy272.303en
dc.identifier.urihttp://hdl.handle.net/10541/621800
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1093/annonc/mdy272.303en
dc.titleEribulin in metastatic breast cancer the UK experience: a multi-centre retrospective 577 patient studyen
dc.typeMeetings and Proceedingsen
dc.contributor.departmentMedical Oncology, Queen Elizabeth-University Hospital Birmingham NHS Foundation Trust, Birmingham, UKen
dc.identifier.journalAnnals of Oncologyen
dc.description.noteen]


This item appears in the following Collection(s)

Show simple item record